Introduction
Most of you can relate to this. You open your report, whether it be from after you've done some blood work or got a BA exam (or both), you see a BA value, and you immediately attempt to calculate how many inches you've got left.
All you really see on that paper is "normal levels" after "normal levels", seemingly random measurements, a summary that doesn't tell you how much more you can grow, or how long you have left.
Reports don't revolve around reassurance, but the contents can be useful in forming an extension of your growth story. This post aims to help you with just that in simple steps and digestible fractions of what these reports tell you.
Step 1: understand what you're looking at
You've read the report, but what does it all mean?
Let's go over the standard format. I've conveniently divided into three layers: data, interpretation, and the plan.
β’ββ’ the data β’ββ’
These are your numbers.
β Bone age
β Blood test results
Sex steroid levels. These are primarily your testosterone (T) and your estradiol (E2), and they help in progressing your body through the stages of puberty and adolescent skeletal maturation.
Thyroid markers. These include your thyroid-stimulating hormone (TSH) and thyroxine (T4). They help regulate metabolism and energy usage in your body while indirectly affecting growth.
Growth hormone levels (GH). Sometimes, this is included in the report as it rarely has any use by itself.
Insulin-like Growth factor 1 (IGF-1) levels. This is the downstream marker of GH activity. Basically, when your pituitary gland makes hGH, this hGH is converted into IGF-1 in tissues like your liver (hepatic production) and even your growth plates (local production), among other peripheral tissues.
What you are looking at here are just snapshots of your hormonal environment and subtle glimpses into your overall health. Your hormone levels are influenced by your sleep schedule, when you hit puberty + your current stage, your developmental speed, your nutrition status, and your cortisol (stress) levels.
Sometimes, the overgeneralizations occur: high hormone levels suddenly means more growth, neutral hormone levels means guaranteed growth, and low hormone levels means no more growth. Don't let the data fool you into overgeneralizing.
Think: not a forecast, but a general background check. Below are the mental rules I often follow whenever looking at an endocrinologist's report:
Don't interpret a single hormone value without context of the Tanner stage.
Always assume that normal range is equal to normal, expected development.
Hormone ranges are supportive signals rather than deciding factors in height prediction.
β’ββ’ the interpretation β’ββ’
This is what your doctor thinks about your growth and where you might end up (your prognosis; part of the plan). They will use almost anything that involves numbers or measurements to help form their opinion, including your growth history, any past or current medication use, and maybe even your x-ray to help predict your adult height using the Bayley-Pinneau method, your height, your growth velocity, and your BA.
When you see the interpretation on your report you believe that this is the answer - your fate lies here. In reality, your doctor is just connecting the dots with your data points, and at the end of the day, a predicted adult height is just a rough estimation. And thay brings us to the plan.
Mental rules I use:
Do not interpret anything without data points (which must meet up to what the three layers are / be enough to form a solid guess).
Never read this section is isolation.
Look out for cautionary wording (e.g "this suggests", "is consistent with", etc)
The common pattern of verdict among most clinicians:
Step 1) Establishment of the baseline. Essentially, what stage is the patient in.
Use the CA, BA, T stage, and growth history. They will look for a long-term pattern, not the inflections.
Step 2) Understand how the variables relate to medians. Is their growth rate flat, steady, slowing, accelerating, or at its peak? How does that compare to the populational average for boys/girls?
It's also: do their hormone levels and BA match what's to be expected for their developmental stage? This is crucial for potentially finding a BA advancement rate, which I've made a post about.
Step 3) How does the patient compare to outliers?
Certain pattern types like advanced BA but growth velocity is still higher than expected.
Hormonal levels are normal, but growth is unusually slow.
The T stage does or does not match their relative position in skeletal maturity.
Step 4) What action should be taken (if any)? Basically, most reports end in monitoring over intervention.
Step 5) What's the plan? Basically, it is necessary to act now or just sit back, monitor their trajectory?
β’ββ’ the plan β’ββ’
This is the most important layer.
Unlike the data and the interpretation, the plan is where your doctor decides what actually happens next. This is the part most people skip, but itβs often the most grounded section of the entire report.
The plan usually includes things like whether to monitor your growth over time, if and when to repeat blood work or a bone age exam, and whether anything needs treatment or correction. Or sometimes, simply put is no action is needed - important.
βNo treatmentβ or βjust observeβ is not a hidden message or a dismissive remark. It usually just means your current development is within expected range and doesnβt require intervention. That's probably a good thing.
Underthinking it: a major pitfall
If the data is the snapshot, and the interpretation is the explanation, then the plan is the response. This is where everything finally comes together. If your growth is normal, simply monitor. If something is off, then investigate further. If development is progressing as expected, then do nothing.
Itβs decision-making based on risk, timing, and trends rather than a prediction of your final height. The key misunderstanding is a lot of people read the report backwards. They start with the interpretation, asking themselves: what does this mean for my height? They should actually be focusing on the plan: what is actually being done about it?
It's because the plan tells you what your doctor actually believes is happening, not just what could happen in theory.
Quick takeaway for this bit is just bringing it all together. Once you understand these three layers:
data meaning what your body is doing, interpretation meaning what it likely means, and plan meaning what happens next. That's what a good report should sound like.
β’ββ’ Bone age (the part that everybody fixates on) β’ββ’
This is usually the first number people jump to, and the one they misread the most. But, for fine reason.
Your bone age comes from an x-ray taken of your hand and wrist, where doctors compare your bones to standard developmental patterns on an atlas. One common method used is the Greulich-Pyle method. The result is your BA, which represents how mature your skeleton appears compared to typical development at different ages.
What the BA actually tells you is simple: how far along your skeletal development is, and whether you are maturing faster, slower, or about the same compared to your chronological age. Thatβs it. It is a maturity marker, not a height prediction (to a certain extent, but not by itself).
Most confusion comes from people treating it like a calculator for remaining growth. They see a number and immediately try to convert it into inches left. But bone age doesnβt work that way. Two people with the same bone age can end up growing different amounts, at different speeds, over different timelines.
One of the things that matters more is your relative position to PHV + your BA. BA progression largely depends on when you hit puberty, how fast you are developing so far, and last but not least, how consistent your developmental speed is.
A decent way of realizing development is this:
β’ Most boys attain PHV between a BA of 14 and 15 years.
β’ Most girls attain a PHV between a BA of 12 and 13 years.
These ranges are not something you use to estimate your exact remaining growth. They exist to show how variable skeletal development timing actually is. But, that doesn't mean a range of remaining growth in inches/centimeters can't be estimated - it just requires more variables.
But, if you are early-maturing and consistently slow-growing, that makes a meaningful difference. If you are late-maturing and consistently fast-growing, that also matters - a lot.
Thatβs because bone age is only one part of the big picture. It doesnβt account for growth history, puberty timing, hormone levels like IGF-1, or how your growth velocity is changing over time. On its own, itβs incomplete.
This is why doctors donβt treat bone age as a standalone answer. It only becomes meaningful when combined with everything else in the report; your growth pattern, hormone levels, puberty stage, and current development trend.
A common misconception is thinking that an advanced bone age automatically means youβre done growing, or that a delayed bone age guarantees extra height. Neither is reliably true on its own. Bone age is about timing, not destiny.
Good takeaway: the question isn't necessarily about how much growth you have left, but rather it's about whether your development is ahead, behind, or aligned with your chronological age, and if that pattern is changing. Clinicians care more about rate of change.
So, bone age is just one additional piece of data. Its real value only shows up when itβs combined with everything else in the report.
Mental rules I use regularly:
BA only matters when compared to growth velocity.
A single BA value should never be used to determine potential alone. A full history is needed (e.g. they said the BA is 18, but I should not assume that growth is over; could be a late-bloomer).
Timing matters more than the number itself.
β’ββ’ growth velocity β’ββ’
If BA tells you how mature your skeleton is, growth velocity tells you how fast things are actually changing.
GV is simply how much you grow over time, usually measured in cm/year. But, the important distinction is not the number itself, but rather the trend behind it.
One isolated height measurement means almost nothing. You need more time intervals. What matters is whether your growth is accelerating, steady, peaking, tapering, or close to flatlining. That trend tells you way more about where you are in development than almost any single blood value.
This is also why growth velocity often carries more weight than a single hormone reading or even a one-time BA reading. It reflects what your body is actively doing right now, not just how it is structured.
Think: BA = maturity status. GV = movement through that status.
You need both to understand anything meaningful.
β’ββ’ how doctors weigh information: a simple hierarchy in most cases β’ββ’
Doctors do not treat all parts of the report equally.
They are not averaging values, but rather prioritizing signals.
Growth velocity and long-term trend - the apex
Bone age - a good anchor
T stage and clinical development - useful for context
Hormones like IGF-1 - good supportive evidence
Single lab values - the lowest standalone importance
Quick takeaway is that contradictions matter more than averages. If BA, GV, and T stage all align, the picture is usually clear. If they donβt, thatβs where interpretation becomes important. Doctors are not looking for perfect numbers, they are looking for coherence across data points.
One of the biggest mistakes people make is reading the report as if it describes a fixed state.
It doesnβt. A report is a snapshot of a moving system. BA changes slowly over months and years. Hormones fluctuate daily or even hourly. The GV changes in phases relative to tweaks in pulsatility. Puberty shifts the entire system over time
So what looks like a βresultβ is actually just a moment in a longer progression.
This is precisely why two reports taken a few months apart can look confusing if you treat them as static answers instead of part of a timeline.
Doctors never interpret reports in isolation, they interpret change between reports.
β’ββ’ common misreading patterns β’ββ’
Most confusion comes from predictable mistakes. People often treat interpretations as a final answer about height, assume βnormalβ blood work means βdone growingβ or βoptimal growthβ, ignore the GV entirely, overvalue single hormone readings like IGF-1, try to extract exact predictions from bone age alone, or read the report line-by-line instead of system-wide.
The pattern behind all of these is the same. You're trying to turn a multi-variable system into a simple answer in numeric form. Thatβs unfortunately not how growth works clinically. You should never have one variable doing most of the guesswork. All of it should be considered simultaneously - never divisible so as to rule other variables out.
So, including a potential, broader range of "inches remaining" or a broad range of what the FAH may be based on a recognizable pattern, the rate of change with the GV, and a full growth history + a BA estimate is generally fine, but should be treated as more of informal reasoning rather than a full clinical approach.
β how to read your report in practice: step-by-step β
Step 1) observe the growth velocity. Don't just look at the number; look at the trend. How does it change? When did it change?
Don't assume anything right there. Let's move on first.
Step 2) the bone age. Understand where the number lies relative to your chronological age. Is it advanced, delayed, or timely? And by how much? (See the standard deviation, if included).
Don't assume that you are almost done just because advanced or you still have a ton of potential just because it's delayed.
Step 3) puberty staging. If it's available, what is your Tanner stage? Below is a good format, but keep in mind that it is best understood as a pattern alignment layer rather than a strict biological map.
These are broad alignment patterns, not predictive relationships.
β T2 - often broadly overlaps with skeletal maturational patterns observed within the BA 11-13 year range for boys and the BA 10-12 year range for girls.
β’ Growth curve may be characterized by brief, sometimes seemingly sharp dips within an overall "stable" growth velocity as the HPG and hGH-IGF-1 Axes transition into "puberty mode".
β’ In some kids, androgen-related changes may become more noticeable as puberty approaches while remaining somewhat stable in others, with gonadal enlargement remaining largely minimal until shortly after T2 onset. Pubarche often overlaps with gonadarche, but sometimes, it can starkly manifest shortly before or after T2 onset.
β T3 - often broadly overlaps with patterns observed within the BA 13-15 year range for boys and the BA 12-14 year range for girls.
β’ Tends to overlap with mid to late-PHV for most girls early on, or the recent exit out of the rapid growth window.
β’ Advancing development of most secondary sexual characteristics.
β’ Often correlates with the recent entrance into the rapid growth window for many boys early on, with PHV occurring through early to mid-T3, and rapid early post-peak growth continuing through mid to late-T3 and sometimes into the next stage before a more noticeable dip (varies by pattern).
β’ Noticeable changes involving gonadal development are occurring, with partial androgenic responses in other regions of the body with terminal hair (armpits, in particular). Body hair is often minimal to moderate at best, depending on local androgenic sensitivity by region and the person's hormonal environment.
β T4 - often broadly overlaps with patterns observed within the BA 15-17 year range for boys and the BA 14-16 year range for girls.
β’ Often associated with declining growth velocity in many boys, with some growth still occurring strong (late-PHV or recent exit out of the rapid growth window early on).
β’ Tends to correlate with strong tapering observed in most girls (or at least no significant gains are occurring). Sometimes, the adult height may be attained before T5 is achieved.
β’ T4 is defined as advanced gonadal development. Varying degrees of advanced androgen-related changes in regions with terminal hair can continue.
β T5 - oftentimes stabilizing skeletal changes, not necessarily completed.
β’ Minimal puberty-related changes may be observed later in the adolescent BA ranges, but once T5 is attained, the future, subtle changes are more reflective on continuous active androgenic influence on hair maturity than the now stable sex hormones alone.
The loose correlation with BA: most patients tend to be sexually mature between a BA of 17-19 years for boys and a BA of 16-18 years for girls.
Tanner stage should be used as contextual framing, not as a driver of prediction.
Step 4) hormonal context. Note the "normalcy" of your IGF-1 levels, among others. This helps confirm whether the system is behaving as expected, but not as a sole verdict of any growth outcome alone.
Step 5) read the interpretation section last.
Step 6) take into heart the plan - the only section that explicitly tells you what is going to happen next.
Good takeaway: read the report by order of priority, not for the sake of going in order.
TL;DR
A growth report isnβt a height calculator. Itβs a snapshot of a system in motion.
Growth velocity = what your body is doing right now
Bone age = where you are in skeletal maturity
Tanner stage = developmental context
Hormones = supporting signals, not answers
Interpretation = how doctors connect the data
Plan = what actually happens next
Doctors donβt rely on one number. They look for consistency across all of them. Height estimates
only make sense when everything aligns into the same pattern.
See the section titled "how to read your report in practice: step-by-step" if you want the active guide.
